Literature DB >> 14744909

Posterior vitreous detachment induced by microplasmin.

Arnd Gandorfer1, Matthias Rohleder, Charanjit Sethi, Dominik Eckle, Ulrich Welge-Lüssen, Anselm Kampik, Philip Luthert, David Charteris.   

Abstract

PURPOSE: To demonstrate the efficacy of microplasmin in inducing posterior vitreous detachment (PVD) and to evaluate the human and the feline retina after treatment.
METHODS: Thirteen human donor eyes were injected with 62.5, 125, or 188 micro g microplasmin. The 13 fellow eyes received balanced salt solution. Four of the microplasmin-treated eyes received an additional intravitreal gas injection. After incubation at 37 degrees C for 30 minutes, all globes were placed in 4% paraformaldehyde. Retinal specimens were processed for scanning (SEM) and transmission (TEM) electron microscopy. Five feline eyes were injected with 14.5- or 25- micro g microplasmin. Animals were killed after 1 day, 3 days, or 3 weeks, and retinal specimens were evaluated by electron and confocal microscopy.
RESULTS: In all control eyes, SEM demonstrated the cortical vitreous covering the inner limiting membrane (ILM). Intravitreal injection of 125 or 188 micro g microplasmin resulted in complete PVD. After treatment with 62.5 micro g microplasmin, SEM revealed collagen fibrils covering the ILM. Additional gas injection did not change the dose necessary for PVD. In vivo in cats, 25 micro g microplasmin resulted in complete PVD after 3 days. After 3 weeks, there was complete PVD with both doses of microplasmin. The retina and the ILM were well preserved in all eyes.
CONCLUSIONS: Both after death and in vivo, microplasmin induces a dose-dependent cleavage between the vitreous cortex and the ILM without morphologic alterations of the retina. In the feline eye, there is no cellular response of retinal glial cells or neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744909     DOI: 10.1167/iovs.03-0930

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.

Authors:  J Sebag; Rafat R Ansari; Kwang I Suh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

2.  Molecular biology of pharmacologic vitreolysis.

Authors:  J Sebag
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.

Authors:  David T Goldenberg; Frank J Giblin; Mei Cheng; Shravan K Chintala; Michael T Trese; Kimberly A Drenser; Alan J Ruby
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

4.  [The primary objective in macular hole surgery. Ultrastructural features of the vitreomacular interface].

Authors:  R G Schumann; M M Schaumberger; M Rohleder; C Haritoglou; A Kampik; A Gandorfer
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

5.  [Pharmacological vitreolysis].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

6.  Lamellar macular hole after intravitreal ocriplasmin injection.

Authors:  Ross Bronson Chod; Clifford Goodrich; Sandeep Saxena; Levent Akduman
Journal:  BMJ Case Rep       Date:  2015-01-09

7.  Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole.

Authors:  Tzyy-Chang Ho; Chung-May Yang; Jen-Shang Huang; Chang-Hao Yang; Muh-Shy Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-23       Impact factor: 3.117

8.  Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.

Authors:  Ricarda G Schumann; Julian Langer; Denise Compera; Katharina Luedtke; Markus M Schaumberger; Thomas Kreutzer; Wolfgang J Mayer; Armin Wolf; Siegfried G Priglinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-28       Impact factor: 3.117

9.  Intravitreal injection of AAV2 transduces macaque inner retina.

Authors:  Lu Yin; Kenneth Greenberg; Jennifer J Hunter; Deniz Dalkara; Kathleen D Kolstad; Benjamin D Masella; Robert Wolfe; Meike Visel; Daniel Stone; Richard T Libby; David Diloreto; David Schaffer; John Flannery; David R Williams; William H Merigan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

10.  Ocriplasmin for treatment of stage 2 macular holes: early clinical results.

Authors:  John B Miller; Leo A Kim; David M Wu; Demetrios G Vavvas; Dean Eliott; Deeba Husain
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Jul-Aug       Impact factor: 1.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.